Gilead exercises option for Kymera's cancer drug candidate KT-200

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/25/2026

1. MU
2. QCOM
3. SPY
4. ICLR
5. JPM
6. USO
7. FUL
8. LAES
9. IBM
10. NNE

Go back to Gilead exercises option for Kymera's cancer drug candidate KT-200
Gilead Sciences (NASDAQ: GILD) Delayed: 125.12 -0.04 (0.03%)
Previous Close $125.16    52 Week High $108.63 
Open $125.27    52 Week Low $71.39 
Day High $126.95    P/E 69.13 
Day Low $124.36    EPS $1.81 
Volume 1,995,205       

(NASDAQ: KYMR) Delayed: 117.45 +17.58 (17.60%)
Previous Close $99.87    52 Week High $ 
Open $108.80    52 Week Low $ 
Day High $130.05    P/E N/A 
Day Low $106.17    EPS $ 
Volume 2,147,933